D&D Pharmatech Inc. (KOSDAQ: 347850)

D&D Pharmatech Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	43,325	15,642	25,504	75,958	60,612	113,057
Cash & Short-Term Investments	43,325	15,642	25,504	75,958	60,612	113,057
Cash Growth	69.88%	-38.67%	-66.42%	25.32%	-46.39%	3328.18%
Accounts Receivable	265.82	263.95	41.84	12.46	0.93	224.67
Other Receivables	1,201	1,165	286.31	94.12	30.84	-
Receivables	1,467	1,429	328.15	106.58	31.76	224.67
Prepaid Expenses	4,667	2,356	7,330	5,507	5,734	4,047
Other Current Assets	111.61	138.64	193.46	121.45	166.43	121.07
Total Current Assets	49,570	19,565	33,355	81,692	66,544	117,450
Property, Plant & Equipment	5,808	6,422	3,024	10,966	8,147	4,471
Long-Term Investments	9,976	10,776	12,326	-	-0	0
Goodwill	10,672	9,905	9,735	34,754	31,895	34,186
Other Intangible Assets	32,382	31,615	34,246	122,689	121,775	136,474
Long-Term Accounts Receivable	69.84	179.43	6.72	7.68	-	-
Other Long-Term Assets	1,048	740.73	948.44	1,000	800.14	1,086
Total Assets	109,526	79,204	93,642	251,109	229,161	293,668
Accrued Expenses	3,871	2,080	6,803	7,647	4,871	1,229
Short-Term Debt	1,675	1,521	19,225	34,836	-	-
Current Portion of Leases	1,415	1,493	1,583	1,276	712.19	594.43
Other Current Liabilities	2,247	2,393	27,312	23,100	3,558	97,422
Total Current Liabilities	9,208	7,487	54,923	66,859	9,141	99,245
Long-Term Debt	-	-	-	-	529.51	-
Long-Term Leases	4,946	5,121	6,425	7,463	4,488	1,930
Long-Term Deferred Tax Liabilities	8,777	8,564	9,239	33,367	33,122	37,253
Other Long-Term Liabilities	2,489	2,801	4,536	5,042	312.79	0
Total Liabilities	25,520	23,986	75,123	112,781	47,854	138,682
Common Stock	5,258	4,649	4,034	4,028	4,019	1,848
Additional Paid-In Capital	334,929	297,522	268,925	268,673	266,338	48,381
Retained Earnings	-300,911	-289,676	-293,610	-157,543	-89,319	-25,913
Comprensive Income & Other	35,777	34,154	30,091	16,951	-204.76	1,560
Total Common Equity	75,054	46,650	9,440	132,109	180,833	25,876
Minority Interest	8,952	8,568	9,079	6,219	474.03	1,086
Shareholders' Equity	84,006	55,218	18,519	138,328	181,307	154,986
Total Liabilities & Equity	109,526	79,204	93,642	251,109	229,161	293,668
Total Debt	8,035	8,134	27,233	43,575	5,730	2,525
Net Cash (Debt)	35,289	7,508	-1,729	32,383	54,881	110,532
Net Cash Growth	-	-	-	-41.00%	-50.35%	3371.41%
Net Cash Per Share	3709.66	800.35	-214.55	3935.19	7513.43	33046.06
Filing Date Shares Outstanding	10.52	9.3	8.07	8.06	8.04	3.7
Total Common Shares Outstanding	10.52	9.3	8.07	8.06	8.04	3.7
Working Capital	40,363	12,078	-21,568	14,834	57,403	18,204
Book Value Per Share	7137.33	5016.66	1170.20	16397.46	22498.20	7002.56
Tangible Book Value	32,000	5,129	-34,541	-25,333	27,163	-144,785
Tangible Book Value Per Share	3043.07	551.59	-4281.72	-3144.37	3379.44	-39182.41
Machinery	3,128	3,250	3,441	3,454	1,945	1,523
Construction In Progress	-	1.7	-	4.78	1,019	112.76

Source: S&P Capital IQ. Standard template. Financial Sources.